Subsidies
Pick a company. You see which programmes comparable companies received over the last five years, how many of them, for what amount, and which the company itself did not receive.
BE 0403.093.693
BAXTER
Manufacture of basic pharmaceutical products and pharmaceutical preparations · Hainaut · Large
Comparison group of 304 companies
The group is made of active legal entities with the same NACE division (21, Pharmaceuticals), across Belgium. Every size counts. The period starts in 2022.
The same region held too few comparable companies. The comparison therefore covers the NACE division across Belgium, any size.
- Flemish subsidies 23% of comparable This company: nothing in this register
- Federal transfers 0.7% of comparable This company: nothing in this register
- Wallonia-Brussels Federation 0% of comparable This company: nothing in this register
- EU budget 3.3% of comparable This company: nothing in this register
- EU research 3.9% of comparable This company: nothing in this register
Programmes BAXTER did not receive according to the registers
At least 2 comparable companies received these programmes since 2022. The most shared come first. That others received a programme does not say whether this company qualifies or whether the programme is still open. The Flemish register publishes the names of its programmes in Dutch only: they appear here as it publishes them.
- Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille) For example ORFIT INDUSTRIES, DEBA PHARMA, BIVIT13% 41 of 304 companies median €1,500 awarded
- Vlaams opleidingsverlof (VOV) For example PFIZER MANUFACTURING BELGIUM, AJINOMOTO OMNICHEM, Janssen Pharmaceutica8.9% 27 of 304 companies median €8,624 awarded
-
5.9% 18 of 304 companies median €9,500 awarded
- Vlaamse ondersteuningspremie (VOP) voor werkgevers (uitdovend stelsel) For example Janssen Pharmaceutica, Organon Heist, PFIZER MANUFACTURING BELGIUM4.6% 14 of 304 companies median €32,465 awarded
- Horizon Europe For example Janssen Pharmaceutica, Quantoom Biosciences, Inteliphage3.9% 12 of 304 companies median €336,435 eu contribution
- Onderzoeksproject For example Janssen Pharmaceutica, Obulytix, Flindr Labs3% 9 of 304 companies median €497,743 awarded
-
2.6% 8 of 304 companies median €1.1m attributed share
- Ontwikkelingsproject For example GENZYME FLANDERS, Janssen Pharmaceutica, SIMABS2.3% 7 of 304 companies median €459,257 awarded
- Baekeland-mandaat For example Janssen Pharmaceutica, Perseus Biomics, Obulytix2% 6 of 304 companies median €330,631 awarded
-
1.6% 5 of 304 companies median €50,000 awarded
-
1.6% 5 of 304 companies median €22,559 awarded
- Werkbaarheidscheque (discontinued) For example LABORATORIA QUALIPHAR, -HEEL BELGIUM, LABORATORIA WOLFS1.6% 5 of 304 companies median €6,000 awarded
Show 9 more
- Strategische transformatiesteun For example GENZYME FLANDERS, Janssen Pharmaceutica, AJINOMOTO OMNICHEM1.3% 4 of 304 companies median €1.0m awarded
-
1.3% 4 of 304 companies median €442,093 awarded
- Kmo-groeisubsidie: steun voor groeitrajecten bij kmo's (discontinued) For example HEW PHARMA, IDEVAX, INTIBIO1.3% 4 of 304 companies median €50,000 awarded
- Innovatiemandaat For example Janssen Pharmaceutica, Ziphius, SIMABS1% 3 of 304 companies median €241,807 awarded
- Innovatieve starterssteun For example Evarmed, FiriX Therapeutics, RheADC1% 3 of 304 companies median €50,000 awarded
- Decentralised Agencies, Joint Undertakings, EU institutions For example Obulytix, Janssen Pharmaceutica0.7% 2 of 304 companies median €1.5m attributed share
-
0.7% 2 of 304 companies median €323,391 awarded
- Premie kwalificerend werkplekleren For example AJINOMOTO OMNICHEM, LAMBO Laboratoria - LAMBO Laboratoires0.7% 2 of 304 companies median €1,000 awarded
- Stagebonus (discontinued) For example GENZYME FLANDERS, BIVIT0.7% 2 of 304 companies median €1,000 awarded